← back to search

Claudia Gebhard

University of Regensburg · DE
Area of research
Molecular Biology · Hematology
Research interest
Research focused on CEBPA and Chromatin, with related work in Atlas (anatomy), Enhancer, Cell biology. Notable publications include 'An atlas of active enhancers across human cell types and tissues', 'An integrated expression atlas of miRNAs and their promoters in human and mouse', and 'Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy'.
h-index
citations
4,326
works
29
NIH funding
primary concept
email

Recent publications

DNA hypomethylation traits define human regulatory T cells in cutaneous tissue and identify their blood recirculating counterparts
Nature Immunology 2025cited by 5position: middledoi
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
Blood Cancer Discovery 2025cited by 4position: middledoi
Lactic acid promotes an MDSC-like phenotype via HIF1α stabilization with impact on prognosis in renal cell carcinoma
Cancer Letters 2025cited by 3position: middledoi
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration
Nature Communications 2025cited by 2position: middledoi
A microbial metabolite protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 1position: middledoi
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy
Cell 2024cited by 191position: middledoi
The effector program of human CD8 T cells supports tissue remodeling
The Journal of Experimental Medicine 2024cited by 30position: middledoi
Single-cell chromatin accessibility and transposable element landscapes reveal shared features of tissue-residing immune cells
Immunity 2024cited by 28position: middledoi
STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemia
Cell Reports 2024cited by 19position: lastdoi
LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling
Signal Transduction and Targeted Therapy 2024cited by 17position: middledoi
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia
Nature Communications 2024cited by 13position: lastdoi
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes
Proceedings of the National Academy of Sciences 2024cited by 3position: middledoi
Pyjacker identifies enhancer hijacking events in acute myeloid leukemia including <i>MNX1</i> activation via deletion 7q
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 2position: middledoi
Darwin’s “neuters” and the evolution of the sex continuum in a superorganism
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 2position: middledoi
S120: MNX1-ACTIVATING ENHANCER HIJACKING EVENTS IN ACUTE MYELOID LEUKEMIA WITH DELETIONS ON CHROMOSOME 7Q
HemaSphere 2023cited by 1position: middledoi
Uterine enrichment of CD8+ T regulatory cells throughout pregnancy prevents fetal loss in mice
Journal of Reproductive Immunology 2023cited by 0position: middledoi
Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy
Proceedings of the National Academy of Sciences 2022cited by 30position: middledoi
Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation
Journal for ImmunoTherapy of Cancer 2022cited by 21position: middledoi
Physiological levels of 25‐hydroxyvitamin D<sub>3</sub> induce a suppressive CD4<sup>+</sup> T cell phenotype not reflected in the epigenetic landscape
Scandinavian Journal of Immunology 2022cited by 7position: middledoi
Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells
Immunity 2021cited by 171position: middledoi
Allele-specific expression of <i>GATA2</i> due to epigenetic dysregulation in <i>CEBPA</i> double-mutant AML
Blood 2021cited by 30position: middledoi
Aberrant <scp>DNA</scp> methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the <scp>CpG</scp> island methylator phenotype
International Journal of Cancer 2021cited by 7position: firstdoi
Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1
Nature Communications 2020cited by 139position: middledoi
Temporal autoregulation during human PU.1 locus SubTAD formation
Blood 2018cited by 19position: middledoi
An integrated expression atlas of miRNAs and their promoters in human and mouse
Nature Biotechnology 2017cited by 603position: middledoi
In-vitro blockade of the CD4 receptor co-signal in antigen-specific T-cell stimulation cultures induces the outgrowth of potent CD4 independent T-cell effectors
Journal of Immunological Methods 2017cited by 2position: middledoi
An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation
Blood 2016cited by 87position: middledoi
An atlas of active enhancers across human cell types and tissues
Nature 2014cited by 2,790position: middledoi
5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes
Genome biology 2013cited by 99position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Rehli · University Hospital Regensburg14 papers (2013–2024)Ruud Delwel · Utrecht University4 papers (2016–2024)Nicholas Strieder · University of Regensburg4 papers (2022–2024)Roger Mulet‐Lazaro · Erasmus MC Cancer Institute4 papers (2021–2024)Claudia Erpelinck-Verschueren · Utrecht University3 papers (2016–2024)Petra Hoffmann · University of Regensburg3 papers (2020–2022)Stanley van Herk · Utrecht University3 papers (2021–2024) · 3 papers (2020–2024)Eric M. Bindels · Erasmus MC3 papers (2016–2021)Philipp Stüve · Leibniz Institute for Immunotherapy2 papers (2022–2024)Noèlia Díaz · Universidade de Santiago de Compostela2 papers (2024–2024)Asmita Pant · University of Regensburg2 papers (2022–2024)Wolfgang Herr · Johannes Gutenberg University Mainz2 papers (2017–2022)Sandra Schmidhofer · University of Regensburg2 papers (2013–2020)Christian Schmidl · University of Regensburg2 papers (2020–2024)Stefan Gröschel · University of Applied Sciences Worms2 papers (2016–2018)Lisa Schmidleithner · University of Regensburg2 papers (2022–2024)Juan M. Vaquerizas · European Bioinformatics Institute2 papers (2024–2024) · 2 papers (2024–2024)Johanna Raithel · University of Regensburg2 papers (2020–2024)